BAL Is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study
- 1 January 2021
- journal article
- letter
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 203 (1) , 136-139
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative studyThe Lancet Respiratory Medicine, 2020
- The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation studyThe Lancet Respiratory Medicine, 2019
- A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2019
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2018
- An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort studyThe Lancet Respiratory Medicine, 2017
- Host–Microbial Interactions in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2017
- The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Acute exacerbation of IPF following diagnostic bronchoalveolar lavage proceduresRespiratory Medicine, 2012
- Bronchoalveolar Lavage as a Possible Cause of Acute Exacerbation in Idiopathic Pulmonary Fibrosis Patients.The Tohoku Journal of Experimental Medicine, 1994